Volpara Health is a globally recognized company that provides clinically validated, AI-powered software for personalized screening and early detection of breast cancer. Their innovative solutions are trusted by over 2,000 facilities and 5,600 mammography technologists worldwide, helping to improve mammogram quality and ensure the best possible care for patients.
With a focus on leveraging science and technology, Volpara Health has assessed breast density for 16.5 million women across 40 countries, empowering individuals with valuable insights for screening. Their commitment to continuous improvement is evident through the analysis of over 100 million mammography and tomosynthesis images, driving advancements in their software and contributing to a healthier future.
Generated from the website